A significant inverse correlation (p<0.001, r = −0.45, R2 = 0.122) was observed between the expression of miR-224 and SMAD4 in these HCC samples (Fig. 4A), suggesting SMAD4 as a clinically relevant miR-224 target in HCC. Here, SMAD4 is linked to hepatocellular carcinoma.